Yhn ScienceBiology first seen 1 d ago, last 54 min ago, peak #5
Drugmakers say GLP-1 weight-loss drugs may slow biological aging
Original: Weight-loss drugs show signs of slowing biological aging, say drugmakers
Eli Lilly and Novo Nordisk report that their GLP-1 weight-loss drugs show signs of slowing biological aging, based on epigenetic aging clocks. The claim, covered by MIT Technology Review, suggests treatments like these could affect aging itself, not just weight and metabolic health. Commenters are debating the strength of the evidence and whether aging-clock data is reliable enough to support such claims.
Why now: The possibility that widely used obesity drugs could also slow aging has major health and market implications, sparking debate over the evidence.
Eli LillyNovo NordiskMIT Technology ReviewGLP-1 drugs
Rank over time, top of the chart is #1. 4 snapshots from 5 h ago to 54 min ago.
Evidence
Elsewhere
API: https://socialmediatrends-api.osmike.com/v1/trends/1279946